The board

**Geoff Siden**
Managing Director

A property developer involved internationally over the last 40 years who has become a serial investor in entrepreneurial opportunities such as Moletest. Previously involved after education (LSE London) in insurance, he moved abroad to widen his experience and build Worldwide Leisure Group Ltd. Currently MD of Moletest (Scotland) Limited and major shareholder.

**Bruce Murray**
Technical Director
*BSc CEng MIMechE MIBC CMC*

Bruce Murray is Technical Director, Moletest (Scotland) Limited. Over two decades with BP Group, including BP Ventures, working with universities and company research centres to develop new products and managing international projects. Worked on all aspects of innovation and system design, product development and marketing strategy in the SME sector. Specific experience in product development, based on mathematical linkage between malignancy at cellular level and image signal analysis.

**Dr. Peter Freedman**
Medical Director
*MA BSc MB BS FRCP*

Medical Director, Moletest (Scotland) Limited. Retired NHS Consultant Physician, Dept. of Metabolic Medicine and Chair of Medical Council, Homerton University Hospital Foundation Trust and Consultant Physician, St Bartholomews and The Royal London Hospitals. Former Director, CANTAB, Clinical Pharmacology. Formerly International Medical Development Director, May & Baker

The management team

**Nick Ager**
Head of IT
*BEng*

Nick Ager is a software architect and developer with over 25 years industry experience. He has successfully delivered projects in start-ups where he is often solely responsible for software development. In more established companies he has managed projects involving teams of significant size. In the last ten years Nick has focused on mobile development in healthcare and at Moletest is responsible for developing the nomela® iPad software and the ecosystem of software that supports it, namely the backend server software, deployment and operational software, clinical trial software and a test suite of software.

**Matthew Blackledge**
Head of AI Development
*PhD MSc*
Team Leader of Computational Imaging, Institute of Cancer Research, London Advisory PanelExpert Advisory Panel
Dr Blackledge has been working in the field of quantitative cancer imaging for over 10 years, having completed his PhD developing whole-body MRI in 2011 at the Institute of Cancer Research, London. He has a track record of developing new mathematical and computational techniques in image analysis for guiding personalized treatment management in cancer patients, including development of Bayesian modelling and deep-learning.
Dr Blackledge's lab specialises in the development of computational techniques for automatic detection, visualisation and quantification of heterogeneous tumour changes using imaging for improving how we guide cancer therapies and reduce toxicity.
The team also focuses on the development of innovations in deep-learning for accelerating image acquisition and improving the accuracy of derived imaging biomarkers.
Other affiliations:
Co-founder of Diafora Medical.

**Ross G.Milligan**
Head of Clinical Photography and Training
MBE FIMI Hon.FIMI BSc

Prior to joining Moletest (Scotland) Limited, Ross had 40 years’ experience as a Clinical Photographer in the National Health Service in Scotland. Specialising in the education of Medical Illustrators, he is primarily involved in the planning, development and delivery of training to nomela® users.

**Marcus Gould**
Head of Regulatory Affairs
*DPhil CBiol CSci*

Marcus is a regulatory affairs professional who devises and implements regulatory strategies for medical device CE Marking and US FDA submissions. At Moletest, Marcus is responsible for leading all aspects of quality assurance and regulatory affairs.

Expert advisory panel

Dr Girish Gupta MB ChB FRCPConsultant Dermatologist, NHS Lothian and Honorary Clinical Associate Professor

Dr Girish Gupta trained in Manchester. His dermatology career has been substantially based in the West of Scotland where in 1999 he was appointed Consultant Dermatologist, NHS Lanarkshire and in 2015 Honorary Clinical Associate Professor in Dermatology, University of Glasgow. Since 2005, he has focused on the management of skin cancer and in 2009 he was appointed as Clinical Lead for the West of Scotland skin cancer network for which he is responsible for the multidisciplinary team meetings, audit and research.

Dr Gupta was appointed Consultant Dermatologist, NHS Lothian and Honorary Clinical Associate Professor in 2019.

Other interests include mole screening, topical therapy of pre-cancerous skin conditions, teledermatology and laser therapy.

He has published widely in peer-reviewed journals and has a chapter in the Textbook of Dermatology on skin cancer.

Memberships

British Association of Dermatologists
European Organisation for Research and Treatment of Skin Cancer
Fellow Royal College of Physicians and Surgeons of Glasgow Scottish Dermatological Society

Learn About Girish

Dr Nigel Burrows MD FRCP Consultant Dermatologist, Cambridge University Hospitals NHS Foundation Trust

Dr Burrows graduated from St Thomas' Hospital, London in 1985 then trained as a dermatology registrar in London and as senior registrar in Cambridge. In 1997 he was appointed as Consultant Dermatologist, Cambridge University Hospitals NHS Foundation Trust at Addenbrooke's Hospital with additional clinics at Newmarket Hospital. He treats both adults and children.

Other Positions held

Clinical lead for Dermatology at Addenbrooke's Hospital, Cambridge
President of the British Society for Paediatric Dermatology.
Staff Governor, Cambridge University Hospitals
Member of the International Consortium on the Ehlers-Danlos syndromes
Member of the Royal Society of Medicine

Areas of interest

General dermatology.
Skin tumours - benign and malignant.
Paediatric dermatology.

Memberships

British Association of Dermatologists
British Society for Paediatric Dermatology

Learn About Nigel

Professor Amanda Lee MSc PhD Chair in Medical Statistics, University of Aberdeen Director of the Institute of Applied Health Sciences, University of Aberdeen

Consultant Statistician NHS Grampian Head of IAHS Postgraduate Education Group.

Following graduation with an MSc Medical Statistics from Newcastle University in 1987, she worked as research statistician in the Cardiovascular Epidemiology Unit, University of Dundee between 1987-1993, then moved to the Wolfson Unit for Peripheral Vascular Diseases, University of Edinburgh as senior research fellow for 9 years. In 2003, she joined the University of Aberdeen as medical statistician for the Department of Primary Care, was made Reader in 2004 and attained Professor in 2006. Professor Lee has been co-applicant on c£11m research grant applications, currently has 280 peer- reviewed publications and an h index of 70.

Learn About Amanda

**Professor George Crooks OBE MBChB FRCP FRCGP**
*Chief Executive of the Digital Health & Care Innovation Centre*

Professor George Crooks OBE MBChB FRCP FRCGP Chief Executive of the Digital Health & Care Institute

Professor George Crooks is the Chief Executive of the Digital Health & Care Institute, Scotland’s national innovation centre for digital health and care. He leads an organisation that is tasked with delivering innovation in digital health and care that will help Scotland’s people to live longer, healthier lives and create new jobs for the economy.

Having worked as a General Medical Practitioner for 23 years in Aberdeen, latterly combining that role as Director of Primary Care for Grampian, he became Medical Director for NHS 24 and Director of the Scottish Centre for Telehealth & Telecare.

Professor Crooks is an expert adviser on digital health to the WHO and European Commission, is on the Board of the European Connected Health Alliance, past President of the European Health Telematics Association and is adjunct Professor of Telehealth at the University of Southern Denmark.

Professor Crooks was awarded an OBE in the Queen's New Year Honours List 2011 for services to healthcare.

Learn About George

Corporate structure

Moletest Limited is a privately-owned company based in Guernsey and has two wholly owned subsidiary companies in the United Kingdom, Moletest (UK) Limited and Moletest (Scotland) Limited.
Moletest (Scotland) Limited has a license agreement with Moletest Limited covering the whole of the United Kingdom.

Contact us

Contact